Join the Oncology Voice Network. Join for Free
How to Break into a PEOPLE MANAGER Role
MSL to leader medical affairs career networking for advancement leadership skills development mentorship in leadership

How to Break into a PEOPLE MANAGER Role


Share This Article


Summary

In this episode, Tom Caravela welcomes Annette Ogbru to discuss her journey from an MSL to a leader in medical affairs. Annette shares her insights on leveraging social media and the importance of networking in career advancement. She emphasizes showcasing leadership skills and maintaining a passion for learning. Annette highlights the significance of formal programs and mentorship in leadership development, empowering others, and embracing humility. She advises on being intentional in leadership and setting career goals, while also recognizing and seizing unexpected opportunities. The episode concludes with Annette's closing thoughts on career progression.

My guest today is Annette Ogbru, Sr Director Medical Affairs, we discuss what it takes to break into a "People Manager" role.
Annette shares….

👉 What skills need to be developed in preparation a people manager role
👉 How can MSLs position themselves for leadership roles
👉 The importance of being a life long learner
👉 Why networking is a huge part of career progression and growth
👉 Mentorship and how it is a 2 way street

Click for Source
MSL to leader, medical affairs career, networking for advancement, leadership skills development, mentorship in leadership

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Leverage YOUR Unique Skills for Career Advantage
Partner Avatar MSL Talk: Tom Caravela, Hahn-Ey Lee

How to Leverage YOUR Unique Skills for Career Advantage

Podcast
Insight about INSIGHTS, and how they can help your MSL career!
Partner Avatar MSL Talk: Tom Caravela, Joe Liberman

Insight about INSIGHTS, and how they can help your MSL career!

Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Article
Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
OVN Avatar R. Kurzrock, L.A. Gurski, R.W. Carlson, D.S. Ettinger, S.M. Horwitz, S.K. Kumar, L. Million, M. von Mehren, A.B. Benson III

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals

Article
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies
OVN Avatar Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Article
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions
OVN Avatar Charles L. Bennett , Sumimasa Nagai , Andrew C. Bennett , Shamia Hoque , Chadi Nabhan , Martin W. Schoen , William J. Hrushesky , Stefano Luminari , Paul Ray , Paul R. Yarnold , Bart Witherspoon , Josh Riente , Laura Bobolts , John Brusk , Rebecca Tombles

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

Explore OVN